[Latest] Global Cancer Cachexia Market Size/Share Worth USD 5.1 Billion by 2033 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Advertisement

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cancer Cachexia Market size & share revenue was valued at approximately USD 3.1 Billion in 2023 and is expected to reach USD 3.3 Billion in 2024 and is expected to reach around USD 5.1 Billion by 2033, at a CAGR of 5.1% between 2024 and 2033. The key market players listed in the report with their sales, revenues and strategies are Pfizer Inc., Novartis International AG, Merck & Co. Inc., Eli Lilly and Company, Bristol Myers Squibb Company, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Takeda Pharmaceutical Company Limited, Amgen Inc., GlaxoSmithKline plc, Bayer AG, Boehringer Ingelheim International GmbH, Sanofi SA, AbbVie Inc., Johnson & Johnson, and others.

Austin, TX, USA, May 03, 2024 (GLOBE NEWSWIRE) — Custom Market Insights has published a new research report titled Cancer Cachexia Market Size, Trends and Insights By Therapeutics (Progestogen, Corticosteroid, Combination Therapy, Other Therapeutics), By Mechanism Of Action (Appetite Stimulators, Weight Loss Stabilizers, Others), By Distribution Channel (Hospital Store, Retail Pharmacy Store, Online Pharmacies), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033 in its research database.

“According to the latest research study, the demand of global Cancer Cachexia Market size & share was valued at approximately USD 3.1 Billion in 2023 and is expected to reach USD 3.3 Billion in 2024 and is expected to reach a value of around USD 5.1 Billion by 2033, at a compound annual growth rate (CAGR) of about 5.1% during the forecast period 2024 to 2033.”

Advertisement

Click Here to Access a Free Sample Report of the Global Cancer Cachexia Market @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=44960

Cancer Cachexia Market: Growth Factors and Dynamics

  • Increasing Cancer Prevalence: The rising incidence and prevalence of cancer globally contribute significantly to the growth of the Cancer Cachexia market. With cancer being a leading cause of morbidity and mortality worldwide, the incidence of cancer-related cachexia is also on the rise. As cancer rates continue to increase, particularly in aging populations, the demand for effective cachexia management strategies grows accordingly.
  • Growing Awareness and Diagnosis: There has been a growing awareness among healthcare professionals regarding the significance of early detection and management of cancer cachexia. Improved understanding of the underlying mechanisms of cachexia and its impact on patient outcomes has led to enhanced diagnostic strategies and earlier intervention. This increased awareness and diagnosis contribute to the expansion of the Cancer Cachexia market.
  • Advancements in Treatment Approaches: Advances in oncology research have led to the development of novel treatment approaches for cancer cachexia. These include targeted therapies aimed at modulating specific molecular pathways involved in cachexia progression, such as inflammation, muscle wasting, and metabolic dysregulation. Additionally, there is ongoing research into personalized medicine approaches to tailor treatments based on individual patient characteristics, further driving market growth.
  • Rising Healthcare Expenditure: The increasing healthcare expenditure, particularly in oncology and supportive care, is fueling the growth of the Cancer Cachexia market. Governments, healthcare providers, and insurance companies are investing in innovative therapies and supportive care services to improve patient outcomes and quality of life. This financial commitment to cancer care extends to the management of cachexia, driving market expansion.
  • Collaborative Research Efforts: Collaborative research efforts involving academia, industry, and patient advocacy groups are playing a crucial role in advancing our understanding of cancer cachexia and developing new treatment modalities. Partnerships and collaborations facilitate the exchange of knowledge, resources, and expertise, accelerating the translation of scientific discoveries into clinical applications. These collaborative efforts contribute to market growth by fostering innovation and expanding the pipeline of potential cachexia therapies.
  • Regulatory Initiatives and Incentives: Regulatory agencies are increasingly recognizing the importance of addressing supportive care needs, including cachexia, in cancer patients. Regulatory initiatives, such as expedited pathways for drug approval and incentives for orphan drug development, encourage investment in research and development targeting unmet medical needs like cancer cachexia. The availability of regulatory pathways and incentives incentivizes pharmaceutical companies to invest in developing innovative therapies for cachexia, driving market growth.

Request a Customized Copy of the Cancer Cachexia Market Report @ https://www.custommarketinsights.com/inquire-for-discount/?reportid=44960

Cancer Cachexia Market: Partnership and Acquisitions

  • In 2022, The team, led by Rutgers Cancer Institute of New Jersey, secured a USD 25 million Cancer Grand Challenges grant to study cancer cachexia, a debilitating condition prevalent in advanced cancer stages. This funding aims to advance understanding and develop effective interventions for cachexia management.
  • In 2023, First Light Acquisition Group and Calidi Biotherapeutics, Inc. announced their merger to form a clinical-stage biotechnology company. Their focus is on developing oncolytic virotherapy using a stem cell-based cancer treatment delivery platform.
  • In 2022, Gilead and Dragonfly have announced a research collaboration to advance natural killer cell engagers in oncology. Gilead obtained a worldwide license from Dragonfly for their 5T4 targeting immunotherapy program DF7001 as part of the agreement.

Report Scope

Feature of the Report Details
Market Size in 2024 USD 3.3 Billion
Projected Market Size in 2033 USD 5.1 Billion
Market Size in 2023 USD 3.1 Billion
CAGR Growth Rate 5.1% CAGR
Base Year 2023
Forecast Period 2024-2033
Key Segment By Therapeutics, Mechanism Of Action, Distribution Channel and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

(A free sample of the Cancer Cachexia report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the following:

  • Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report.
  • The COVID-19 Pandemic Outbreak Impact Analysis is included in the package.
  • About 220+ Pages Research Report (Including Recent Research)
  • Provide detailed chapter-by-chapter guidance on the Request.
  • Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2024
  • Includes Tables and figures have been updated.
  • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis 
  • Custom Market Insights (CMI) research methodology

(Please note that the sample of the Cancer Cachexia report has been modified to include the COVID-19 impact study prior to delivery.)

Request a Customized Copy of the Cancer Cachexia Market Report @ https://www.custommarketinsights.com/report/cancer-cachexia-market/


Cancer Cachexia Market: COVID-19 Analysis

The COVID-19 pandemic has had a significant impact on the Cancer Cachexia Market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:

  • Disruption of Healthcare Services: The COVID-19 pandemic led to disruptions in healthcare services globally, including delays in cancer screenings, diagnosis, and treatments. As a result, many cancer patients face challenges in accessing timely care, including the management of cancer cachexia. The focus on managing COVID-19 patients and minimizing the risk of infection also diverted resources away from supportive care services for cancer patients, potentially exacerbating symptoms of cachexia.
  • Clinical Trials Disruptions: Many clinical trials investigating novel therapies for cancer cachexia were either suspended or delayed due to the pandemic. Restrictions on patient recruitment, limitations on in-person visits, and prioritization of COVID-19-related research affected the progress of ongoing trials and hindered the initiation of new studies. This slowdown in clinical research could delay the development and approval of promising cachexia treatments, impacting the Cancer Cachexia market.
  • Resumption of Healthcare Services: As COVID-19-related restrictions ease and healthcare systems stabilize, efforts to resume and prioritize cancer care services, including supportive care for cachexia, will be crucial. Healthcare facilities may implement strategies such as telemedicine, extended clinic hours, and streamlined processes to address the backlog of cancer diagnoses and treatments, ensuring timely management of cachexia.
  • Focus on Patient Education and Support: Patient education and support programs can play a vital role in mitigating the impact of COVID-19 on cancer cachexia management. Healthcare providers can leverage telehealth platforms to deliver education on nutrition, physical activity, and symptom management to cancer patients remotely. Additionally, virtual support groups and counseling services can provide emotional and social support to patients experiencing cachexia-related challenges.
  • Accelerated Research and Development: There may be increased focus and investment in research and development targeting cancer cachexia in the post-pandemic period. Pharmaceutical companies, academic institutions, and research organizations may prioritize the development of innovative therapies for cachexia, leveraging insights gained from COVID-19 research and therapeutic developments. Expedited regulatory pathways and funding incentives may further stimulate R&D efforts in this area.

In conclusion, the COVID-19 pandemic has had a mixed impact on the Cancer Cachexia Market, with some challenges and opportunities arising from the pandemic.

Request a Customized Copy of the Cancer Cachexia Market Report @ https://www.custommarketinsights.com/report/cancer-cachexia-market/

Key questions answered in this report:

  • What is the size of the Cancer Cachexia market and what is its expected growth rate?
  • What are the primary driving factors that push the Cancer Cachexia market forward?
  • What are the Cancer Cachexia Industry’s top companies?
  • What are the different categories that the Cancer Cachexia Market caters to?
  • What will be the fastest-growing segment or region?
  • In the value chain, what role do essential players play?
  • What is the procedure for getting a free copy of the Cancer Cachexia market sample report and company profiles?

Key Offerings:

  • Market Share, Size & Forecast by Revenue | 2024−2033
  • Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends
  • Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Buy this Premium Cancer Cachexia Research Report | Fast Delivery Available – [220+ Pages] @ https://www.custommarketinsights.com/report/cancer-cachexia-market/

Cancer Cachexia Market – Regional Analysis

The Cancer Cachexia Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region:

  • North America: In North America, a significant trend in the Cancer Cachexia Market is the focus on research and development, with a high concentration of pharmaceutical companies and academic institutions conducting clinical trials and developing innovative therapies for cachexia management. Additionally, there is an increasing emphasis on integrated care models, involving multidisciplinary teams to address cachexia-related symptoms and improve patient outcomes.
  • Europe: In Europe, a notable trend in the Cancer Cachexia Market is the growing adoption of personalized medicine approaches, with efforts to tailor cachexia treatments based on individual patient characteristics and disease profiles. Moreover, there is a rising awareness of cachexia among healthcare professionals, leading to improved diagnosis and management practices across the region.
  • Asia-Pacific: In the Asia-Pacific region, a key trend in the Cancer Cachexia Market is the expanding healthcare infrastructure and access to cancer care services, particularly in emerging economies. This growth is accompanied by increased investment in supportive care programs and nutritional support services to address cachexia-related needs among cancer patients. Additionally, there is a rising demand for affordable and culturally sensitive cachexia management options in the region.
  • LAMEA (Latin America, Middle East, and Africa): In the LAMEA region, a notable trend in the Cancer Cachexia Market is the rising prevalence of cancer and cachexia, coupled with efforts to improve cancer care infrastructure and access to supportive care services. This trend is driving the adoption of innovative therapies and nutritional interventions to address cachexia-related symptoms and enhance patient well-being across diverse healthcare settings in the region.

Request a Customized Copy of the Cancer Cachexia Market Report @ https://www.custommarketinsights.com/report/cancer-cachexia-market/

(We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.)

Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media 

Email Directly Here with Detail Information: [email protected]

Browse the full Cancer Cachexia Market Size, Trends and Insights By Therapeutics (Progestogen, Corticosteroid, Combination Therapy, Other Therapeutics), By Mechanism Of Action (Appetite Stimulators, Weight Loss Stabilizers, Others), By Distribution Channel (Hospital Store, Retail Pharmacy Store, Online Pharmacies), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033 Report at https://www.custommarketinsights.com/report/cancer-cachexia-market/

List of the prominent players in the Cancer Cachexia Market:

  • Pfizer Inc.
  • Novartis International AG
  • Merck & Co. Inc.
  • Eli Lilly and Company
  • Bristol Myers Squibb Company
  • AstraZeneca PLC
  • Hoffmann-La Roche Ltd.
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • GlaxoSmithKline plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Sanofi SA
  • AbbVie Inc.
  • Johnson & Johnson
  • Others

Click Here to Access a Free Sample Report of the Global Cancer Cachexia Market @  https://www.custommarketinsights.com/report/cancer-cachexia-market/

Spectacular Deals

  • Comprehensive coverage
  • Maximum number of market tables and figures
  • The subscription-based option is offered.
  • Best price guarantee
  • Free 35% or 60 hours of customization.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantees are available.
  • Personalized market brief by author.

Browse More Related Reports: 

India Healthtech MarketIndia Healthtech Market Size, Trends and Insights By Technology (Digital Health Systems, Health Analytics, Health Information Technology, mHealth, Telehealthcare), By Component (Hardware, Software, Services), By End-User (Healthcare Providers, Healthcare Payers, Healthcare Consumers, Pharmaceutical Companies, Others), By Applications (Cardiology, Diabetes, Neurology, Sleep Apnea, Oncology, Others), By Delivery Modes (Cloud-Based, On-premises), and By Region – Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

Prostate Cancer Market: Prostate Cancer Market Size, Trends and Insights By Drug Class (Hormonal ADT, AR-directed Therapies, Cytotoxic Agents, Bone Metastases Therapeutic Vaccines, PARP Inhibitors, Kinase Inhibitors, PSMA-Targeted Radioligands), By Biomarker Expression (PSA Levels, Genetic Markers, Androgen Receptor Status, HER2 Expression), By Distribution Channel (Hospital Pharmacies, Drug Store & Retail Pharmacies, Online Pharmacies), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

Lung Cancer Liquid Biopsy Market: Lung Cancer Liquid Biopsy Market Size, Trends and Insights By Biomarker Type (CTC (Circulating Tumor Cells), ctDNA (Circulating tumor DNA), Exosomes and RNA), By Application (Small Cell Lung Cancer and, Non-Small Cell Lung Cancer), By End-User (Diagnostic and Imaging Centres, Hospitals, Academic and Research Centers, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

Oral Cancer Treatment Market: Oral Cancer Treatment Market Size, Trends and Insights By Type (Oral Squamous Cell Carcinoma, Oral Verrucous Carcinoma, Mucoepidermoid Carcinoma, Oral Cavity Lymphomas), By Therapy Type (Chemotherapy, Radiation Therapy, Biological Therapy), By Treatment (Medication, Surgery), By Route of Administration (Oral, Injectable, Others), By End Users (Hospitals, Homecare, Specialty Clinics, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

Colon Cancer Screening Market: Colon Cancer Screening Market Size, Trends and Insights By Screening Methods (Fecal Occult Blood Tests (FOBT), Fecal Immunochemical Tests (FIT), Stool DNA Tests, Colonoscopy, Flexible Sigmoidoscopy, Virtual Colonoscopy (CT Colonography)), By Age Group (Below 50 years, 50-64 years, Above 65 years), By End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, Research Institutes), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

Colon Cancer Diagnostic Market: Colon Cancer Diagnostic Market Size, Trends and Insights By Diagnostic Test Type (Colonoscopy, Fecal occult blood test (FOBT), Fecal immunochemical test (FIT), Stool DNA test (FIT-DNA), Virtual Colonoscopy, Flexible Sigmoidoscopy, Biopsy), By Technology (Endoscopy, Imaging, Molecular Diagnostics, Blood-Based Biomarker Testing, Immunohistochemistry), By Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors,, Others), By End User (Hospitals, Diagnostic laboratories, Ambulatory surgical centers, Clinics), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033

The Cancer Cachexia Market is segmented as follows:

By Therapeutics

  • Progestogen
  • Corticosteroid
  • Combination Therapy
  • Other Therapeutics

By Mechanism Of Action

  • Appetite Stimulators
  • Weight Loss Stabilizers
  • Others

By Distribution Channel

  • Hospital Store
  • Retail Pharmacy Store
  • Online Pharmacies

Click Here to Get a Free Sample Report of the Global Cancer Cachexia Market @ https://www.custommarketinsights.com/report/cancer-cachexia-market/

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America

Europe

  • Germany
  • France
  • U.K.
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

This Cancer Cachexia Market Research/Analysis Report Contains Answers to the following Questions.

  • Which Trends Are Causing These Developments?
  • Who Are the Global Key Players in This Cancer Cachexia Market? What are Their Company Profile, Product Information, and Contact Information?
  • What Was the Global Market Status of the Cancer Cachexia Market? What Was the Capacity, Production Value, Cost and PROFIT of the Cancer Cachexia Market?
  • What Is the Current Market Status of the Cancer Cachexia Industry? What’s Market Competition in This Industry, Both Company and Country Wise? What’s Market Analysis of Cancer Cachexia Market by Considering Applications and Types?
  • What Are Projections of the Global Cancer Cachexia Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports?
  • What Is Cancer Cachexia Market Chain Analysis by Upstream Raw Materials and Downstream Industry?
  • What Is the Economic Impact On Cancer Cachexia Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends?
  • What Are Market Dynamics of Cancer Cachexia Market? What Are Challenges and Opportunities?
  • What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Cancer Cachexia Industry?

Click Here to Access a Free Sample Report of the Global Cancer Cachexia Market @ https://www.custommarketinsights.com/report/cancer-cachexia-market/

Reasons to Purchase Cancer Cachexia Market Report

  • Cancer Cachexia Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors.
  • Cancer Cachexia Market report outlines market value (USD) data for each segment and sub-segment.
  • This report indicates the region and segment expected to witness the fastest growth and dominate the market.
  • Cancer Cachexia Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region.
  • The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled.
  • Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players.
  • The Industry’s current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions.
  • Cancer Cachexia Market Includes in-depth market analysis from various perspectives through Porter’s five forces analysis and provides insight into the market through Value Chain.

Reasons for the Research Report

  • The study provides a thorough overview of the global Cancer Cachexia market. Compare your performance to that of the market as a whole.
  • Aim to maintain competitiveness while innovations from established key players fuel market growth.

Buy this Premium Cancer Cachexia Research Report | Fast Delivery Available – [220+ Pages] @  https://www.custommarketinsights.com/report/cancer-cachexia-market/

What does the report include?

  • Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide Cancer Cachexia market analysis.
  • The competitive environment of current and potential participants in the Cancer Cachexia market is covered in the report, as well as those companies’ strategic product development ambitions.
  • According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions.
  • For each segment mentioned above, actual market sizes and forecasts have been given.

Who should buy this report?

  • Participants and stakeholders worldwide Cancer Cachexia market should find this report useful. The research will be useful to all market participants in the Cancer Cachexia industry.
  • Managers in the Cancer Cachexia sector are interested in publishing up-to-date and projected data about the worldwide Cancer Cachexia market.
  • Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Cancer Cachexia products’ market trends.
  • Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans. 

Request a Customized Copy of the Cancer Cachexia Market Report @ https://www.custommarketinsights.com/report/cancer-cachexia-market/

About Custom Market Insights:

Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains.

CMI provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey.

Follow Us: LinkedIn | Twitter | Facebook | YouTube

Contact Us:

Joel John

CMI Consulting LLC

1333, 701 Tillery Street Unit 12,

Austin, TX, Travis, US, 78702

USA: +1 801-639-9061

India: +91 20 46022736

Email: [email protected]

Web: https://www.custommarketinsights.com/

Blog: https://www.techyounme.com/

Blog: https://atozresearch.com/

Blog: https://www.technowalla.com/

Blog: https://marketresearchtrade.com/

Buy this Premium Cancer Cachexia Research Report | Fast Delivery Available – [220+ Pages] @ https://www.custommarketinsights.com/report/cancer-cachexia-market/

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.